fingolimod hydrochloride has been researched along with Eye Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airody, A; Gale, RP; Heath, G | 1 |
| Graham, SL; Gupta, VK; Klistorner, A; You, Y | 1 |
1 review(s) available for fingolimod hydrochloride and Eye Disorders
| Article | Year |
|---|---|
The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Eye Diseases; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferons; Mitoxantrone; Multiple Sclerosis; Natalizumab | 2017 |
1 other study(ies) available for fingolimod hydrochloride and Eye Disorders
| Article | Year |
|---|---|
Focus on molecules: Sphingosine 1 Phosphate (S1P).
Topics: Animals; Calcium Channels; Cell Proliferation; Cell Survival; Eye Diseases; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Intermediate Filament Proteins; Lysophospholipids; Membrane Glycoproteins; Nerve Tissue Proteins; Opsins; Peripherins; Propylene Glycols; Receptors, Lysosphingolipid; Retinal Photoreceptor Cell Outer Segment; Rhodopsin; Sphingosine | 2012 |